These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31758934)

  • 41. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies.
    Sun Y; Wang W; Guo Y; Zheng B; Li H; Chen J; Zhang W
    Toxicol Appl Pharmacol; 2019 Feb; 365():101-111. PubMed ID: 30641075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic signature of follicular fluid in infertility-related diseases: a narrative review.
    Fiscus J; Fraison É; Renault L; Salle B; Panthu B; Labrune E
    Reprod Biomed Online; 2024 Jun; 48(6):103762. PubMed ID: 38537523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metal oxide-based dispersive solid-phase extraction coupled with mass spectrometry analysis for determination of ribose conjugates in human follicular fluid.
    Chu JM; Yin TL; Zheng SJ; Yang J; Yuan BF; Feng YQ
    Talanta; 2017 May; 167():506-512. PubMed ID: 28340751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UPLC/Q‑TOF‑MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome.
    Fan X; Jiang J; Huang Z; Gong J; Wang Y; Xue W; Deng Y; Wang Y; Zheng T; Sun A; Luo G
    Mol Med Rep; 2019 Jan; 19(1):280-292. PubMed ID: 30431132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-Müllerian hormone in women with polycystic ovary syndrome.
    Pehlivanov BK; Orbetzova MM
    Folia Med (Plovdiv); 2011; 53(1):5-10. PubMed ID: 21644399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
    Sørensen AE; Wissing ML; Englund AL; Dalgaard LT
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1579-89. PubMed ID: 26771704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment.
    Cordeiro FB; Cataldi TR; do Vale Teixeira da Costa L; de Lima CB; Stevanato J; Zylbersztejn DS; Ferreira CR; Eberlin MN; Cedenho AP; Turco EG
    J Assist Reprod Genet; 2015 Jan; 32(1):45-54. PubMed ID: 25374394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
    Shen Q; Bi H; Yu F; Fan L; Zhu M; Jia X; Kang J
    Mol Reprod Dev; 2019 Apr; 86(4):370-378. PubMed ID: 30633842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome.
    Wu R; Fujii S; Ryan NK; Van der Hoek KH; Jasper MJ; Sini I; Robertson SA; Robker RL; Norman RJ
    Hum Reprod; 2007 Feb; 22(2):527-35. PubMed ID: 16997933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment.
    Omabe M; Elom S; Omabe KN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):221-229. PubMed ID: 29359679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of leptin mRNA in luteinized granulosa cells and leptin levels in serum and follicular fluid of non-obese infertile patients with polycystic ovary syndrome].
    Lu XP; Wang B; Huang HF
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):88-91. PubMed ID: 15774212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome.
    Kim YS; Gu BH; Choi BC; Kim MS; Song S; Yun JH; Chung MK; Choi CH; Baek KH
    Int J Mol Med; 2013 Mar; 31(3):707-16. PubMed ID: 23338533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome.
    Magoffin DA; Jakimiuk AJ
    Hum Reprod; 1998 Oct; 13(1O):2693-8. PubMed ID: 9804215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
    Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study.
    Castiglione Morelli MA; Iuliano A; Schettini SCA; Petruzzi D; Ferri A; Colucci P; Viggiani L; Cuviello F; Ostuni A
    Metabolomics; 2019 Jan; 15(2):19. PubMed ID: 30830455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: study protocol for a randomized controlled trial.
    Ni CM; Huang WL; Jiang YM; Xu J; Duan R; Zhu YL; Zhu XP; Fan XM; Luo GA; Wang YM; Li YY; He Q; Xu L
    Trials; 2020 Feb; 21(1):169. PubMed ID: 32046752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients.
    Liu L; Yin TL; Chen Y; Li Y; Yin L; Ding J; Yang J; Feng HL
    J Steroid Biochem Mol Biol; 2019 Jan; 185():142-149. PubMed ID: 30121347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation.
    Dai G; Lu G
    Reprod Fertil Dev; 2012; 24(7):893-904. PubMed ID: 22935150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application of metabolomics in treating polycystic ovary syndrome with berberine based on ultra high performance liquid chromatography-mass spectrometry].
    Li Y; Zhang C; Zhang H; Zhao X; Hou L; Xu G
    Se Pu; 2014 May; 32(5):464-71. PubMed ID: 25185305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment.
    Zhao T; Xiao X; Li L; Zhu J; He W; Zhang Q; Wu J; Wu X; Yuan T
    Front Endocrinol (Lausanne); 2024; 15():1354214. PubMed ID: 38948525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.